I wasn't familiar with them but I did have this link bookmarked http://www.amirapharm.com/pipeline.html So they must have PR'd something some time ago. I am still looking for some nice way to play IPF (i.e. public, not a huge market cap and most importantly promising drug(s)). I must admit to not doing as a good of job the past few years in keeping track of the landscape.
It seems more and more speculative companies have PR'd something (most probably junk/long shots). An alert the other day bought up this trial http://clinicaltrials.gov/ct2/show/NCT01335477 So there appears to be another Phase 3 candidate. They supplied InterMune with Actimmune and believe they had x-US rights as well.